LecturaInvestigaciónRadarMarco de inversión
Iniciar sesión / Registrarse
← Volver a la lectura
NoticiasTema · Nolla AI处方试点Material1 min de lecturaEditorial de DisconfirmAI

Utah Approves First AI-Prescribed Acne Meds

Nolla Health received Utah authorization for its AI to issue acne prescriptions directly, moving from real-time doctor sign-off to post-hoc review.

2026-10-05 22:35 GMT+8

Nolla Health has become the first US company authorized by a state regulator to allow AI to issue initial prescriptions.

Previously, every prescription required a licensed clinician's signature. The new pilot permits the AI to generate prescriptions directly within strict limits (topical acne meds only), shifting doctors to after-the-fact or sample-based review.

The rollout has three stages: the first 100 patients require dual real-time physician approval; the next 500 involve direct AI issuance with weekly physician review; the final stage involves monthly audits of at least 10% of cases. Progression requires 95% agreement with physicians and zero serious adverse events.

This model addresses dermatologist shortages but explicitly excludes high-risk drugs like isotretinoin and severe cases.

Fuentes

  • nollahealth.com↗
Tema

Nolla AI处方试点

Nolla Health获犹他州批准,成为全美首家通过AI系统自主开具初始痤疮处方的机构。该试点利用Nolla Derm应用,通过面部扫描和问卷在10-15分钟内生成治疗方案,月费4.99美元,旨在解决医疗资源匮乏地区的皮肤科就诊难问题。

3 pasos

Iniciar sesión / Registrarse
LecturaInvestigaciónRadarMarco de inversión
2 piezas
Actualizado 2026-10-08 07:14

Cómo llegó hasta aquí

  1. 2026-10-05Nolla Health宣布获得犹他州授权,启动全美首个AI自主开具初始痤疮处方的试点项目。nollahealth.com ↗
  2. 2026-10-06多家媒体跟进报道,详细披露试点的三阶段监督模型及安全过渡指标。nullbot.ai ↗
  3. 2026-10-07ABC News确认试点细节,强调AI仅在特定低风险条件下开方,且受州级AI沙盒计划保护。abcnews.com ↗

Lo que aún está pendiente

  • FDA是否会认定犹他州的AI沙盒豁免权侵犯了联邦对药品处方的管辖权?
  • 在第二阶段(AI直接开方、医生事后审查)中,如何量化‘零严重不良事件’以确保持续合规?
  • 该模式能否成功复制到非痤疮类、但同样标准化的疾病(如流感、尿路感染)?

También en este hilo

  • Utah Approves Autonomous AI Acne Prescriptions2026-10-06
Leer el tema completo →
Continuar investigando →